Spots Global Cancer Trial Database for cd19+ lymphoid malignancies
Every month we try and update this database with for cd19+ lymphoid malignancies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies | NCT00968760 | Lymphoma B-cell Lymphoma | Leukapheresis Stem Cell Trans... CD19-specific T... IL-2 Carmustine Etoposide Cytarabine Melphalan | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood | NCT01497184 | Leukemia Lymphoma | HSCT DLI | 1 Year - 65 Years | M.D. Anderson Cancer Center |